Imaging method can determine breast cancer treatment course

10/31/2010 | HealthImaging.com

British researchers used an imaging method combining hyperpolarized [1-13C]pyruvate and [1,4-13C2]fumarate to determine whether a model of human breast adenocarcinoma is responding to doxorubicin therapy. "Our new imaging method not only shows early evidence that treatment is working but could also help predict the long-term outcome. We expect that these techniques will have an impact for patients in the near future," a researcher said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA